Kodiak Sciences Inc
KOD7.310USD
+0.660+9.92%
收盘 08/04, 16:00（美东）报价延迟15分钟
385.62M总市值
亏损市盈率 TTM
关于 Kodiak Sciences Inc 公司
Kodiak Sciences Inc. 是一家生物制药公司。该公司开发了一种用于视网膜药物的新技术平台，即抗体生物聚合物偶联物 (ABC) 平台。其 ABC 平台利用分子工程将基于蛋白质的疗法和基于化学的疗法融合在一起。其领先的在研药物 tarcocimab 是一种新型抗血管内皮生长因子 (anti-VEGF) 抗体生物聚合物偶联物，正在开发中，用于治疗高发性视网膜血管疾病，包括糖尿病性视网膜病变（发达国家工作年龄患者失明的原因）和湿性年龄相关性黄斑变性（老年患者失明的原因）。其第二种在研药物 KSI-501 是一种双特异性抗体生物聚合物偶联物，靶向促炎细胞因子白细胞介素 6 (IL-6) 和 VEGF。该公司还在开发第三种在研药物 KSI-101，这是一种靶向 IL-6 和 VEGF 的非偶联双特异性蛋白。
公司简介
公司代码KOD
公司名称Kodiak Sciences Inc
上市日期Oct 04, 2018
CEODr. Victor Perlroth, M.D.
员工数量109
证券类型Ordinary Share
年结日Oct 04
公司地址1250 Page Mill Road
城市PALO ALTO
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编94304
电话16502810850
网址https://kodiak.com/
公司代码KOD
上市日期Oct 04, 2018
CEODr. Victor Perlroth, M.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. John A. Borgeson
Mr. John A. Borgeson
Chief Financial Officer, Executive Vice President, Secretary
Chief Financial Officer, Executive Vice President, Secretary
183.32K
+0.63%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Independent Director
Independent Director
25.95K
--
Mr. Robert A. Profusek, J.D.
Mr. Robert A. Profusek, J.D.
Lead Independent Director
Lead Independent Director
10.00K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
1.00K
--
Dr. Taiyin Yang, Ph.D.
Dr. Taiyin Yang, Ph.D.
Independent Director
Independent Director
--
--
Dr. Victor Perlroth, M.D.
Dr. Victor Perlroth, M.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Felix J. Baker, Ph.D.
Dr. Felix J. Baker, Ph.D.
Independent Director
Independent Director
--
--
Dr. Bassil I. Dahiyat, Ph.D.
Dr. Bassil I. Dahiyat, Ph.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. John A. Borgeson
Mr. John A. Borgeson
Chief Financial Officer, Executive Vice President, Secretary
Chief Financial Officer, Executive Vice President, Secretary
183.32K
+0.63%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Independent Director
Independent Director
25.95K
--
Mr. Robert A. Profusek, J.D.
Mr. Robert A. Profusek, J.D.
Lead Independent Director
Lead Independent Director
10.00K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
1.00K
--
Dr. Taiyin Yang, Ph.D.
Dr. Taiyin Yang, Ph.D.
Independent Director
Independent Director
--
--
Dr. Victor Perlroth, M.D.
Dr. Victor Perlroth, M.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Baker Bros. Advisors LP
32.81%
BlackRock Institutional Trust Company, N.A.
5.37%
Perlroth (Victor D)
5.11%
Acadian Asset Management LLC
3.69%
The Vanguard Group, Inc.
3.20%
Other
49.82%
持股股东
持股股东
占比
Baker Bros. Advisors LP
32.81%
BlackRock Institutional Trust Company, N.A.
5.37%
Perlroth (Victor D)
5.11%
Acadian Asset Management LLC
3.69%
The Vanguard Group, Inc.
3.20%
Other
49.82%
股东类型
持股股东
占比
Hedge Fund
46.97%
Investment Advisor
18.19%
Investment Advisor/Hedge Fund
13.56%
Individual Investor
5.53%
Research Firm
1.50%
Endowment Fund
1.31%
Pension Fund
0.18%
Venture Capital
0.09%
Bank and Trust
0.07%
Other
12.61%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
273
46.04M
87.25%
-8.22M
2025Q1
302
46.32M
87.78%
-8.84M
2024Q4
308
44.88M
85.29%
-7.98M
2024Q3
318
42.74M
81.24%
-12.36M
2024Q2
326
43.49M
82.78%
-12.58M
2024Q1
345
46.64M
88.83%
-7.18M
2023Q4
377
44.39M
84.60%
-13.12M
2023Q3
391
45.97M
87.64%
-8.18M
2023Q2
401
46.07M
88.00%
-6.85M
2023Q1
414
44.84M
85.66%
-7.92M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Baker Bros. Advisors LP
17.31M
32.81%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.83M
5.37%
-21.30K
-0.75%
Mar 31, 2025
Perlroth (Victor D)
2.70M
5.11%
+527.00K
+24.31%
Mar 31, 2025
Acadian Asset Management LLC
1.95M
3.69%
+413.82K
+27.01%
Mar 31, 2025
The Vanguard Group, Inc.
1.69M
3.2%
+6.61K
+0.39%
Mar 31, 2025
Adage Capital Management, L.P.
1.33M
2.51%
+186.18K
+16.34%
Mar 31, 2025
ICONIQ Capital, LLC
1.27M
2.4%
+249.70K
+24.56%
Mar 31, 2025
TCG Crossover Management, LLC
1.15M
2.17%
--
--
Mar 31, 2025
Point72 Asset Management, L.P.
1.07M
2.03%
+548.67K
+104.76%
Mar 31, 2025
Boxer Capital Management, LLC
1.03M
1.96%
+35.00K
+3.50%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Fidelity Enhanced Small Cap ETF
0.04%
iShares Micro-Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Schwab U.S. Small-Cap ETF
0%
Virtus LifeSci Biotech Clinical Trials ETF
0%
ProShares UltraPro Russell2000
0%
Vanguard US Momentum Factor ETF
0%
查看更多
Fidelity Enhanced Small Cap ETF
占比0.04%
iShares Micro-Cap ETF
占比0.03%
Avantis US Small Cap Equity ETF
占比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
iShares Russell 2000 Value ETF
占比0.01%
Invesco RAFI US 1500 Small-Mid ETF
占比0.01%
Schwab U.S. Small-Cap ETF
占比0%
Virtus LifeSci Biotech Clinical Trials ETF
占比0%
ProShares UltraPro Russell2000
占比0%
Vanguard US Momentum Factor ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
